478
Views
59
CrossRef citations to date
0
Altmetric
Original Research

Pivotal role of Acitretin nanovesicular gel for effective treatment of psoriasis: ex vivo–in vivo evaluation study

, , , &
Pages 1059-1079 | Published online: 20 Feb 2018

References

  • BrownMBMartinGPJonesSAAkomeahFKDermal and transdermal drug delivery systems: current and future prospectsDrug Deliv200613317518716556569
  • FlatzLConradCRole of T-cell-mediated inflammation in psoriasis: pathogenesis and targeted therapyPsoriasis Target Ther20133110
  • DanielsenKOlsenAOWilsgaardTFurbergASIs the prevalence of psoriasis increasing? A 30–year follow-up of a population–based cohortBr J Dermatol201316861303131023374051
  • MichalekIMLoringBJohnSMA systematic review of worldwide epidemiology of psoriasisJ Eur Acad Dermatol Venereol201731220521227573025
  • NickoloffBJNestleFORecent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunitiesJ Clin Invest2004113121664167515199399
  • LowesMABowcockAMKruegerJGPathogenesis and therapy of psoriasisNature2007445713086687317314973
  • PradhanMSinghDSinghMRNovel colloidal carriers for psoriasis: current issues, mechanistic insight and novel delivery approachesJ Control Release2013170338039523770117
  • HashizumeHItoTYagiHEfficacy and safety of preprandial versus postprandial administration of low-dose cyclosporin microemulsion (Neoral) in patients with psoriasis vulgarisJ Dermatol200734743043417584318
  • ClarkRAGone but not forgotten: lesional memory in psoriatic skinJ Invest Dermatol2011131228328521228808
  • AzfarRSGelfandJMPsoriasis and metabolic disease: epidemiology and pathophysiologyCurr Opin Rheumatol200820441642218525354
  • MichaRImamuraFWyler von BallmoosMSystematic review and meta-analysis of methotrexate use and risk of cardiovascular diseaseAm J Cardiol201110891362137021855836
  • HeydendaelVMSpulsPIOpmeerBCMethotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasisN Engl J Med2003349765866512917302
  • LebwohlMTingPKooJPsoriasis treatment: traditional therapyAnn Rheum Dis200564Suppl 2ii83ii8615708945
  • SureshPKSinghPSarafSNovel topical drug carriers as a tool for treatment of psoriasis: progress and advancesAfr J Pharm Pharmacol201375138147
  • RichardEGHönigsmannHPhototherapy, psoriasis, and the age of biologicsPhotodermatol Photoimmunol Photomed20143013724313462
  • KofoedKSkovLZachariaeCNew drugs and treatment targets in psoriasisActa Derm Venereol201595213313925111317
  • AndrewsSNJeongEPrausnitzMRTransdermal delivery of molecules is limited by full epidermis, not just stratum corneumPharm Res20133041099110923196771
  • SuYHFangJYDrug delivery and formulations for the topical treatment of psoriasisExpert Opin Drug Deliv20085223524918248321
  • NestleFOKaplanDHBarkerJPsoriasisN Engl J Med2009361549650919641206
  • RahmanMAkhterSAhmadJAhmadMZBegSAhmadFJNanomedicine-based drug targeting for psoriasis: potentials and emerging trends in nanoscale pharmacotherapyExpert Opin Drug Deliv201512463565225439967
  • MarianecciCDi MarzioLRinaldiFNiosomes from 80s to present: the state of the artAdv Colloid Interface Sci201420518720624369107
  • ThakkarMBrijeshSOpportunities and challenges for niosomes as drug delivery systemsCurr Drug Deliv20161381275128927017826
  • MoghassemiSHadjizadehANano-niosomes as nanoscale drug delivery systems: an illustrated reviewJ Control Release2014185223624747765
  • HamishehkarHRahimpourYKouhsoltaniMNiosomes as a propitious carrier for topical drug deliveryExpert Opin Drug Deliv201310226127123252629
  • KumarGPRajeshwarraoPNonionic surfactant vesicular systems for effective drug delivery–an overviewAPSB201114208219
  • AroraRJainCPAdvances in niosome as a drug carrier: a reviewAJP2007112939
  • PilkingtonTBrogdenRNAcitretin: a review of its pharmacology and therapeutic useDrugs1992434597627
  • SurberCLaugierJPGeigerJMBunHDurandAMaibachHIHigh-performance liquid chromatography determination of acitretin in plasma and its application to a pharmacokinetic study in human subjectsPharm Res1992910136513691448441
  • CarreteroGRiberaMBelinchónIGuidelines for the use of acitretin in psoriasisActas Dermosifiliogr2013104759861623891453
  • KatzHIWaalenJLeachEEAcitretin in psoriasis: an overview of adverse effectsJ Am Acad Dermatol1999413 Pt 2S7S1210459140
  • SurberCWilhelmKPBermannDMaibachHIIn vivo skin penetration of acitretin in volunteers using three sampling techniquesPharm Res1993109129112948234165
  • DunnLKGaarLRYentzerBAO’NeillJLFeldmanSRAcitretin in dermatology: a reviewJ Drugs Dermatol201110777278221720660
  • PastuszkaMKaszubaAAcitretin, a systemic retinoid for the treatment of psoriasis-current state of knowledgePost Dermatol Alergol20114285292
  • LoftssonTSigurđardóttirAMÓlafssonJHImproved acitretin delivery through hairless mouse skin by cyclodextrin complexationInt J Pharm19951152255258
  • AgrawalYPetkarKCSawantKKDevelopment, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasisInt J Pharm20104011–29310220858539
  • DivyaGPanonnummalRGuptaSJayakumarRSabithaMAcitretin and aloe-emodin loaded chitin nanogel for the treatment of psoriasisEur J Pharm Biopharm20161079710927368748
  • BaillieAJFlorenceATHumeLRMuirheadGTRogersonAThe preparation and properties of niosomes non-ionic surfactant vesiclesJ Pharm Pharmacol198537128638682868092
  • AzeemAAhmadFJKhanZITalegaonkarSNonionic surfactant vesicles as a carrier for transdermal delivery of frusemideJ Dispers Sci Technol2008295723730
  • MokhtarMSammourOAHammadMAMegrabNAEffect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomesInt J Pharm20083611–210411118577437
  • FangJYHongCTChiuWTWangYYEffect of liposomes and niosomes on skin permeation of enoxacinInt J Pharm20012191–2617211337166
  • RuckmaniKJayakarBGhosalSKNonionic surfactant vesicles (niosomes) of cytarabine hydrochloride for effective treatment of leukemias: encapsulation, storage, and in vitro releaseDrug Dev Ind Pharm200026221722210697760
  • HuCRhodesDGProniosomes: a novel drug carrier preparationInt J Pharm19991851233510425362
  • SloanKBBeallHDWeimarWRVillanuevaRThe effect of receptor phase composition on the permeability of hairless mouse skin in diffusion cell experimentsInt J Pharm199173297104
  • JacobsenJBuccal iontophoretic delivery of atenolol HCl employing a new in vitro three-chamber permeation cellJ Control Release2001701–2839511166410
  • El-KattanAFAsbillCSMichniakBBThe effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systemsInt J Pharm2000198217918910767567
  • GurrapuAJukantiRBobbalaSRKanugantiSJeevanaJBImproved oral delivery of valsartan from maltodextrin based proniosome powdersAdv Powder Technol2012235583590
  • GoyalGGargTMalikBChauhanGRathGGoyalAKDevelopment and characterization of niosomal gel for topical delivery of benzoyl peroxideDrug Deliv20152281027104224251352
  • ManconiMSinicoCValentiDLaiFFaddaAMNiosomes as carriers for tretinoin. III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoinInt J Pharm20063111–2111916439071
  • HiguchiTMechanism of sustained-action mediation. Theoretical analysis of rate of release of solid drugs dispersed in solid matricesJ Pharm Sci1963521145114914088963
  • KorsmeyerRWGurnyRDoelkerEBuriPPeppasNAMechanisms of solute release from porous hydrophilic polymersInt J Pharm19831512535
  • RitgerPLPeppasNAA simple equation for description of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discsJ Control Release1987512336
  • MadyFMShakerMAEnhanced anticancer activity and oral bioavailability of ellagic acid through encapsulation in biodegradable polymeric nanoparticlesInt J Nanomedicine2017127405741729066891
  • ShakerDSShakerMAHanafyMSCellular uptake, cytotoxicity and in vivo evaluation of Tamoxifen citrate loaded niosomesInt J Pharm20154931–228529426200748
  • DraizeJHWoodardGCalveryHOMethods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranesJ Pharmacol Exp Ther1944823377390
  • ManosroiAChankhampanCManosroiWManosroiJTransdermal absorption enhancement of papain loaded in elastic niosomes incorporated in gel for scar treatmentEur J Pharm Sci201348347448323266464
  • NagleAGoyalAKKesarlaRMurthyRREfficacy study of vesicular gel containing methotrexate and menthol combination on parakeratotic rat skin modelJ Liposome Res201121213414020557280
  • SinghalMKansaraNCassia toraLCreams inhibit psoriasis in mouse tail modelPharm Crop2012316
  • LaxmiRJKarthikeyanRSrinivasa BabuPNarendra BabuRVVFormulation and evaluation of antipsoriatic gel using natural excipientsJ Acute Dis201322115121
  • VijayalakshmiARavichandiranVVelrajMAnti-Psoriatic activity of smilax china linn. rhizomeIJPER20134718289
  • KhuranaSJainNKBediPMNanostructured lipid carriers based nanogel for meloxicam delivery: mechanistic, in vivo and stability evaluationDrug Dev Ind Pharm20154181368137525151872
  • UchegbuIFVyasSPNon-ionic surfactant based vesicles (niosomes) in drug deliveryInt J Pharm19981721–23370
  • AgarwalRKatareOPVyasSPPreparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranolInt J Pharm20012281–2435211576767
  • DevarajGNParakhSRDevrajRApteSSRaoBRRambhauDRelease studies on niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterolJ Colloid Interface Sci2002251236036516290741
  • El-MenshaweSFHusseinAKFormulation and evaluation of meloxicam niosomes as vesicular carriers for enhanced skin deliveryPharm Dev Technol201318477978621913880
  • El-SamaligyMSAfifiNNMahmoudEAIncreasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigationInt J Pharm20063081–214014816356669
  • LinganMASathaliAAHKumarMRVGokilaAFormulation and evaluation of topical drug delivery system containing clobetasol propionate niosomesSci Revs Chem Commun201111717
  • FathallaDAbdel-MageedAAbdel-HamidFAhmedMIn vitro and in vivo evaluation of niosomal gel containing aceclofenac for sustained drug deliveryIJPSR20141111
  • ZakiRMAliAAEl MenshaweSFAbdelBaryAFormulation and in vitro evaluation of diacerein loaded niosomesInt J Pharm Pharm Sci20146Suppl 2515521
  • VermaDDVermaSBlumeGFahrAParticle size of liposomes influences dermal delivery of substances into skinInt J Pharm20032581–214115112753761
  • GuptaRGuptaMMangalSAgrawalUVyasSPCapsaicin-loaded vesicular systems designed for enhancing localized delivery for psoriasis therapyArtif Cells Nanomed Biotechnol201644382583425465045
  • LasońESikoraEOgonowskiJInfluence of process parameters on properties of Nanostructured Lipid Carriers (NLC) formulationActa Biochim Pol201360477377724432330
  • ReddyLHMurthyRSEtoposide-loaded nanoparticles made from glyceride lipids: formulation, characterization, in vitro drug release, and stability evaluationAAPS PharmSciTech200562E158E16616353973
  • SarmentoBFerreiraDVeigaFRibeiroACharacterization of insulin-loaded alginate nanoparticles produced by ionotropic pre-gelation through DSC and FTIR studiesCarbohydr Polym200666117
  • Sezgin-BayindirZYukselNInvestigation of formulation variables and excipient interaction on the production of niosomesAAPS PharmSciTech201213382683522644706
  • RahmanSAAbdelmalakNSBadawiAElbayoumyTSabryNEl RamlyAFormulation of tretinoin-loaded topical proniosomes for treatment of acne: in vitro characterization, skin irritation test and comparative clinical studyDrug Deliv201522673173924670094
  • JadonPSGajbhiyeVJadonRSGajbhiyeKRGaneshNEnhanced oral bioavailability of griseofulvin via niosomesAAPS PharmSciTech20091041186119219856107
  • KumarGKarthikLRaoKVBAntimicrobial activity of latex of calotropis gigantea against pathogenic microorganisms. An in vitro studyPhOL20103155163
  • AliMFSalemHFAbdelmohsenHFAttiaSKPreparation and clinical evaluation of nano-transferosomes for treatment of erectile dysfunctionDrug Des Devel Ther2015924312447
  • AbdellatifAATawfeekHMTransfersomal nanoparticles for enhanced transdermal delivery of clindamycinAAPS PharmSciTech20161751067107426511937
  • WuHLiuZPengJDesign and evaluation of baicalin-containing in situ pH-triggered gelling system for sustained ophthalmic drug deliveryInt J Pharm20114101–2314021397671
  • OgisoTNiinakaNIwakiMMechanism for enhancement effect of lipid disperse system on percutaneous absorptionJ Pharm Sci199685157648926585
  • BarryBWNovel mechanisms and devices to enable successful trans-dermal drug deliveryEur J Pharm Sci200114210111411500256
  • KilfoyleBESheihetLZhangZLaohooMKohnJMichniak- KohnBBDevelopment of paclitaxel-TyroSpheres for topical skin treatmentJ Control Release20121631182422732474
  • BarakatHSDarwishIAEl-KhordaguiLKKhalafallahNMDevelopment of naftifine hydrochloride alcohol-free niosome gelDrug Dev Ind Pharm200935563163718989805
  • Abu HashimIIEl-DahanMSYusifRMAbd-ElGawadAHArimaHPotential use of niosomal hydrogel as an ocular delivery system for atenololBiol Pharm Bull201437454155124694602
  • PaolinoDCoscoDMuzzalupoRTrapassoEPicciNFrestaMInnovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancerInt J Pharm20083531–223324218191509
  • ShaikhKPawarAAphaleSMogheAEffect of vesicular encapsulation on in vitro cytotoxicity of ciclopirox olamineInt J Drug Deliv201242139146
  • ZareiMNorouzianDHonarvarBMohammadiMShamabadiHEAkbarzadehAPaclitaxel loaded niosome nanoparticle formulation prepared via reverse phase evaporation method: an in vitro evaluationPak J Biol Sci201316629529824498794
  • UnRNBarlasFBYavuzMPhyto-Niosomes: in vitro assessment of the novel nanovesicles containing marigold extractInt J Polym Mater20156417927937
  • ZhangYZhangKWuZEvaluation of transdermal salidroside delivery using niosomes via in vitro cellular uptakeInt J Pharm2015478113814625448576
  • LeMottePKKeidelSApfelCMCharacterization of synthetic retinoids with selectivity for retinoic acid or retinoid X nuclear receptorsBiochim Biophys Acta1996128922983048600988
  • ChandraratnaRARational design of receptor-selective retinoidsJ Am Acad Dermatol1998394 Pt 2S124S1289777789
  • DiazBVLenoirMCLadouxAFrelinCDémarchezMMichelSRegulation of vascular endothelial growth factor expression in human keratinocytes by retinoidsJ Biol Chem2000275164265010617662
  • PfhalMThe molecular mechanism of retinoid action–retinoids today and tomorrowRetinoid Dermatol19964426
  • SauratJHRetinoids and psoriasis: novel issues in retinoid pharmacology and implications for psoriasis treatmentJ Am Acad Dermatol1999413 Pt 2S2S610459139
  • ArmstrongJLRuizMBoddyAVRedfernCPFPearsonADJVealGJIncreasing the intracellular availability of all-trans retinoic acid in neuroblastoma cellsBr J Cancer200592469670415714209
  • ElderJTAströmAPetterssonURetinoic acid receptors and binding proteins in human skinJ Invest Dermatol1992986 SupplS36S41
  • MucidaDParkYKimGReciprocal TH17 and regulatory T-cell differentiation mediated by retinoic acidScience2007317583525626017569825
  • WernerBBreschMBrennerFMLimaHCComparative study of histopathological and immunohistochemical findings in skin biopsies from patients with psoriasis before and after treatment with acitretinJ Cutan Pathol200835330231018251745
  • NiuXCaoWMaHFengJLiXZhangXAcitretin exerted a greater influence on T-helper (Th)1 and Th17 than on Th2 cells in treatment of psoriasis vulgarisJ Dermatol2012391191692122913391
  • GuentherLCTopical tazarotene therapy for psoriasis, acne vulgaris, and photoagingSkin Therapy Lett20027314
  • ThielitzAGollnickHTopical retinoids in acne vulgaris: update on efficacy and safetyAm J Clin Dermatol20089636938118973403
  • DubeyAPrabhuPKabrawalaHGhateVNiosomal gel of Adapalene: its formulation, physicochemical properties and evaluation for mild-acneAdv Biomed Pharma2015212231
  • BarkerJNThe pathophysiology of psoriasisLancet199133887612272301676787
  • GudjonssonJEJohnstonADysonMValdimarssonHElderJTMouse models of psoriasisJ Invest Dermatol200712761292130817429444
  • PalHCChamcheuJCAdhamiVMTopical application of delphinidin reduces psoriasiform lesions in the flaky skin mouse model by inducing epidermal differentiation and inhibiting inflammationBr J Dermatol2015172235436425533330
  • NakagumaHKambaraTYamamotoTRat ultraviolet ray B photodermatitis: an experimental model of psoriasis vulgarisInt J Exp Pathol199576165737734340
  • SobolevaAGMezentsevAVBruskinSAGenetically modified animals as model systems of psoriasisMol Biol (Mosk)2014484587599 Russian25842844
  • MarianecciCRinaldiFMastriotaMAnti-inflammatory activity of novel ammonium glycyrrhizinate/niosomes delivery system: human and murine modelsJ Control Release20121641172523041542
  • AbdelbaryAAAbouGhalyMHDesign and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in vitro evaluation and in vivo skin deposition studyInt J Pharm20154851–223524325773359
  • LakshmiPKDeviGSBhaskaranSSacchidanandSNiosomal methotrexate gel in the treatment of localized psoriasis: phase I and phase II studiesIndian J Dermatol Venereol Leprol200773315716117558046